Latest filing published 25 Aug 2026 for Anterix Inc., €1.9M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Christopher Guttman-Mccabe: trading record in brief
All filings by Christopher Guttman-Mccabe on record concern Anterix Inc. Between 15 June 2026 and 25 August 2026, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 25 August 2026, the filings show a transaction worth €1.9M in Anterix Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher Guttman-Mccabe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,439 shares@ US$92.3605CommonSEC144:0001950047-26-008663
- 122,852 shares@ US$81.74670.50% mcap100.0% of flowCommonSEC144:0001950047-26-006117
2 of 2 declarations
